OS with multivariable regression analysis
. | HR . | 95% CI . | Overall P . |
---|---|---|---|
OS (≤12 mo) | <.0001 | ||
HCT | 1 | ||
Non-HCT | 0.325 | 0.260, 0.406 | |
OS (>12 mo) | <.0001 | ||
HCT | 1 | ||
Non-HCT | 2.109 | 1.656, 2.685 | |
DIPSS at HCT/referral | <.0001 | ||
Low | 1 | ||
Int-1 | 2.237 | 1.683, 2.973 | |
Int-2 | 3.327 | 2.496, 4.435 | |
High | 5.672 | 3.810, 8.443 | |
KPS at HCT/referral | <.0001 | ||
≥90% | 1 | ||
<90% | 1.713 | 1.485, 1.977 | |
Cytogenetics | .0004 | ||
Favorable (normal) | 1 | ||
Favorable (other) | 1.040 | 0.868, 1.245 | |
Unfavorable | 1.453 | 1.214, 1.740 | |
Ruxolitinib | <.0001 | ||
No | 1 | ||
Yes | 0.530 | 0.444, 0.633 |
. | HR . | 95% CI . | Overall P . |
---|---|---|---|
OS (≤12 mo) | <.0001 | ||
HCT | 1 | ||
Non-HCT | 0.325 | 0.260, 0.406 | |
OS (>12 mo) | <.0001 | ||
HCT | 1 | ||
Non-HCT | 2.109 | 1.656, 2.685 | |
DIPSS at HCT/referral | <.0001 | ||
Low | 1 | ||
Int-1 | 2.237 | 1.683, 2.973 | |
Int-2 | 3.327 | 2.496, 4.435 | |
High | 5.672 | 3.810, 8.443 | |
KPS at HCT/referral | <.0001 | ||
≥90% | 1 | ||
<90% | 1.713 | 1.485, 1.977 | |
Cytogenetics | .0004 | ||
Favorable (normal) | 1 | ||
Favorable (other) | 1.040 | 0.868, 1.245 | |
Unfavorable | 1.453 | 1.214, 1.740 | |
Ruxolitinib | <.0001 | ||
No | 1 | ||
Yes | 0.530 | 0.444, 0.633 |